Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

Abstract and Introduction Rationale for DPP Lifestyle Intervention Key Features ... and substitute lower fat foods and cooking methods. Session 4. Healthy Eating Emphasize the importance of ...

DPP-4 inhibitors help lower blood sugar levels only ... where it can be used for energy. Biguanides are taken twice a day. The only medication in this class is metformin (Glucophage).